The DOI matches its Crossref record; 724 of the 724 references it cites were found in a registry or an index.
Purinergic Signalling: Therapeutic Developments
Open accessAbstract
Purinergic signalling, i.e. the role of nucleotides as extracellular signalling molecules, was proposed in 1972. However, this concept was not well accepted until the early 1990’s when receptor subtypes for purines and pyrimidines were cloned and characterised, which includes 4 subtypes of the P1 (adenosine) receptor, 7 subtypes of P2X ion channel receptors and 8 subtypes of the P2Y G protein-coupled receptor. Early studies were largely concerned with the physiology, pharmacology and biochemistry of purinergic signalling. More recently, the focus has been on the pathophysiology and therapeutic potential. There was early recognition of the use of P1 receptor agonists for the treatment of supraventicular tachycardia and A2A receptor antagonists are promising for the treatment of Parkinson’s disease. Clopidogrel, a P2Y¬12 antagonist, is widely used for the treatment of thrombosis and stroke, blocking P2Y¬12 receptor-mediated platelet aggregation. Diquafasol, a long acting P2Y¬2 receptor agonist, is being used for the treatment of dry eye. P2X3 receptor antagonists have been developed that are orally bioavailable and stable in vivo and are currently in clinical trials for the treatment of chronic cough, bladder incontinence, visceral pain and hypertension. Antagonists to P2X7 receptors are being investigated for the treatment of inflammatory disorders, including neurodegenerative diseases. Other investigations are in progress for the use of purinergic agents for the treatment of osteoporosis, myocardial infarction, irritable bowel syndrome, epilepsy, atherosclerosis, depression, autism, diabetes and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 601–724 of 724
Pool, L. R., Wagner, R. M., Scott, L. L., Roychowdhury, D., Berhane, R., Wu, C., Pearson, K., Sutton, J. A., & Schaffer, W. T. (2015) · The FASEB Journal · doi:10.1096/fj.14-264358 · Cited by 23
Pharmacology of the Adenosine A3 Receptor in the Vasculature and Essential Hypertension
Ho, M., Low, L. M., & Rose’Meyer, R. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150021 · Cited by 23
Impaired P2X1 Receptor–Mediated Adhesion in Eosinophils from Asthmatic Patients
Wright, A. K. A., Mahaut‐Smith, M. P., Symon, F. A., Sylvius, N. B., Ran, S., Bafadhel, M., Muessel, M. J., Bradding, P., Wardlaw, A. J., & Vial, C. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501585 · Cited by 23
Purinergic Signaling in Corneal Wound Healing: A Tale of 2 Receptors
Minns, M., & Trinkaus‐Randall, V. (2016) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2016.0009 · Cited by 23
Lemaire, A., Vanorlé, M., Horckmans, M., di Pietrantonio, L., Clouet, S., Robaye, B., Boeynaems, J., & Communi, D. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0166 · Cited by 23
Pharmacology of Adenosine Receptors and Their Signaling Role in Immunity and Inflammation
Lapa, F. D. R., Macedo-Júnior, S. J., Cerutti, M. L., & Santos, A. R. S. (2014) · InTech eBooks · doi:10.5772/57206 · Cited by 22
Frenguelli, B. G., & Wall, M. J. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.09.011 · Cited by 22
Tao, Y., & Liang, G. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0162-7 · Cited by 22
Mittal, R., Chan, B., Grati, M., Mittal, J., Patel, K., Debs, L. H., Patel, A. P., Yan, D. L. S., Chapagain, P. P., & Liu, X. Z. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25274 · Cited by 22
Giorgi, V. S. I., Witkin, S. S., Castro, C. F. B., Sartori, M. S., Romão‐Veiga, M., Borges, V. T. M., Peraçoli, J. C., & Peraçoli, M. T. S. (2016) · Pregnancy Hypertension · doi:10.1016/j.preghy.2016.09.004 · Cited by 22
Zheng, X., Li, T., Chen, Y., Pan, H., Zhang, Z., Dai, Y., & Wang, J. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.05.003 · Cited by 22
Kehasse, A., Rich, C. B., Lee, A., McComb, M. E., Costello, C. E., & Trinkaus‐Randall, V. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.08.015 · Cited by 21
Richards, J. P., Bowles, E. A., Gordon, W. R., Ellsworth, M. L., Stephenson, A. H., & Sprague, R. S. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00420.2014 · Cited by 21
Jia, X., Naito, H., Yetti, H., Tamada, H., Kitamori, K., Hayashi, Y., Yamagishi, N., Wang, D., Yanagiba, Y., Ito, Y., et al. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.04.029 · Cited by 21
P2X7 receptor in skin biology and diseases
Geraghty, N. J., Watson, D., Adhikary, S. R., & Sluyter, R. (2016) · World Journal of Dermatology · doi:10.5314/wjd.v5.i2.72 · Cited by 21
Purinergic signaling in infection and autoimmune disease
Savio, L. E. B., & Coutinho‐Silva, R. (2016) · Biomedical Journal · doi:10.1016/j.bj.2016.09.002 · Cited by 21
Kira, S., Yoshiyama, M., Tsuchiya, S., Shigetomi, E., Miyamoto, T., Nakagomi, H., Shibata, K., Mochizuki, T., Takeda, M., & Koizumi, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-00824-2 · Cited by 21
Choi, K., Tai, C., Tzeng, C., et al. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.102.006551 · Cited by 20
Baranowska‐Bosiacka, I., Listos, J., Gutowska, I., Machoy‐Mokrzyńska, A., Kolasa, A., Tarnowski, M., Puchałowicz, K., Prokopowicz, A., Talarek, S., Listos, P., et al. (2015) · Toxicology · doi:10.1016/j.tox.2015.10.003 · Cited by 20
Zhou, X. J., Ma, L., Xiong, Y., Huang, H., Yuan, J., Li, R.-H., Li, J.-N., & Chen, Y. (2016) · Neurochemical Research · doi:10.1007/s11064-015-1820-x · Cited by 20
Kaiser, M., Penk, A., Franke, H., Krügel, U., Nörenberg, W., Huster, D., & Schaefer, M. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9523-6 · Cited by 20
Luo, Y., Feng, C., Wu, J., Wu, Y., Liu, D., Wu, J., Dai, F., & Zhang, J. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4320-1 · Cited by 20
Adenosine 2 A receptors modulate reward behaviours for methamphetamine
Chesworth, R., Brown, R. M., Kim, J. H., Ledent, C. A., & Lawrence, A. J. (2015) · Addiction Biology · doi:10.1111/adb.12225 · Cited by 19
Hupertan, V., Neuzillet, Y., Stücker, O., Pons, C., Leammel, E., & Lebrét, T. (2012) · International Journal of Andrology · doi:10.1111/j.1365-2605.2012.01290.x · Cited by 19
Tang, L., Zhu, J.-F., Wang, F., Qian, J., Zhu, J., Mo, Q., Lu, H., Li, G.-Q., & Wang, X.-H. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.02.084 · Cited by 19
Thymidine 5'-O-monophosphorothioate induces HeLa cell migration by activation of the P2Y6 receptor
Gendaszewska‐Darmach, E., & Szustak, M. (2016) · Purinergic Signalling · doi:10.1007/s11302-015-9492-1 · Cited by 19
Ramos, D. B., Müller, G. C., Rocha, G. B. M., Dellavia, G. H., Almeida, R. F., Pettenuzzo, L. F., Loureiro, S. O., Hansel, G., Horn, Â. C. M., Souza, D. O., et al. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9489-9 · Cited by 19
Turčin, A., Dolžan, V., Porcelli, S., Serretti, A., & Plesničar, B. K. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0003 · Cited by 19
Silencing of MUC8 by siRNA increases P2Y2-induced airway inflammation
Cha, H., Jung, M.-S., Ahn, D. W., Choi, J.-K., Ock, M. S., Kim, K. S., Yoon, J., Song, E. J., & Song, K. S. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00332.2014 · Cited by 18
Endogenous A1 adenosine receptor protects mice from acute ethanol-induced hepatotoxicity
Yang, P., Wang, Z., Zhan, Y., Wang, T., Zhou, M., Xia, L., Yang, X. Y., & Zhang, J. (2013) · Toxicology · doi:10.1016/j.tox.2013.05.003 · Cited by 18
Yelovitch, S., Barr, H. M., Camden, J. M., Weisman, G. A., Shai, E., Varon, D., & Fischer, B. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3006355 · Cited by 18
Kurlak, L. O., Williams, P. J., Bulmer, J. N., Pipkin, F. B., & Mistry, H. D. (2015) · Placenta · doi:10.1016/j.placenta.2015.02.011 · Cited by 18
Enhanced A2A adenosine receptor-mediated increase in coronary flow in type I diabetic mice
Labazi, H., Teng, B., Zhou, Z., & Mustafa, S. J. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.033 · Cited by 18
Abraham, M.-K., Nolte, A., Reus, R., Behring, A., Zengerle, D., Avci‐Adali, M., Hohmann, J. D., Peter, K., Schlensak, C., Wendel, H. P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138375 · Cited by 18
The Adenosinergic System in Diabetic Retinopathy
Vindeirinho, J., Santiago, A. R., Cavadas, C., Ambrósio, A. F., & Santos, P. F. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4270301 · Cited by 18
Inhibition of Adenosine Kinase Attenuates Acute Lung Injury*
Köhler, D., Streienberger, A., Morote–Garcia, J. C., Granja, T., Schneider, M., Straub, A., Boison, D., & Rosenberger, P. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001370 · Cited by 18
Marchenkova, A., van den Maagdenberg, A. M. J. M., & Nistri, A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.034 · Cited by 18
Purinergic signaling in schistosomal infection
Silva, C. L. M. (2016) · Biomedical Journal · doi:10.1016/j.bj.2016.06.006 · Cited by 18
Dysregulation of select ATP-dependent chromatin remodeling factors in high trait anxiety
Wille, A., Amort, T., Singewald, N., Sartori, S. B., & Lusser, A. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.036 · Cited by 17
ATP and arterial calcification
Fish, R. S., Klootwijk, E. D., Tam, F. W. K., Kleta, R., Wheeler, D. C., Unwin, R. J., & Norman, J. T. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12055 · Cited by 17
Aronsson, P., Johnsson, M., Veselá, R., Winder, M., & Tobin, G. (2012) · Autonomic Neuroscience · doi:10.1016/j.autneu.2012.10.006 · Cited by 17
Guo, J., Fu, X., Cui, X., & Fan, M. (2014) · The Journal of Physiological Sciences · doi:10.1007/s12576-014-0344-5 · Cited by 17
Purinergic Signaling on Leukocytes Infiltrating the LPS-Injured Lung
Friebe, D., Yang, T., Schmidt, T., Borg, N., Steckel, B., Ding, Z., & Schrader, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095382 · Cited by 17
The effect of adenosine and adenosine analogues on methylxanthine-induced hypercaliuria in the rat
McPhee, M. D., & Whiting, S. J. (1989) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y89-203 · Cited by 17
Putative roles of purinergic signaling in human immunodeficiency virus-1 infection
Pacheco, P. A. F., Faria, R. X., Ferreira, L. G., & Paixão, I. C. N. D. P. (2014) · Biology Direct · doi:10.1186/1745-6150-9-21 · Cited by 17
P2Y12receptor inhibitors for secondary prevention of ischemic stroke
Liu, F., Tantry, U. S., & Gurbel, P. A. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1035256 · Cited by 17
CD73 protects kidney from ischemia‐reperfusion injury through reduction of free radicals
Jian, R., Sun, Y., Wang, Y., Yu, J., Zhong, L., & Zhou, P. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02827.x · Cited by 17
P2X7 receptor antagonist activity of the anti-allergic agent oxatomide
Yoshida, K., Ito, M., & Matsuoka, I. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.10.002 · Cited by 17
Yang, Z., Li, L., Zheng, J., Ma, H., Tian, S., Li, J., Zhang, H., Zhen, X., & Zhang, X. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00218 · Cited by 17
Xu, X., Zheng, S., Xiong, Y., Wang, X., Qin, W., Zhang, H., & Sun, B. (2017) · Inflammation Research · doi:10.1007/s00011-016-1021-3 · Cited by 17
Vascular and inflammatory actions of P2X receptors in renal injury
Howarth, A. R., Conway, B. R., & Bailey, M. A. (2015) · Autonomic Neuroscience · doi:10.1016/j.autneu.2015.05.001 · Cited by 16
Xiao, H., Si, L., Liu, W., Li, N., Meng, G., Yang, N., Chen, X., Zhou, Y., & Shen, H. (2012) · Acta Histochemica · doi:10.1016/j.acthis.2012.09.002 · Cited by 16
Walsh, C. A., Cheng, Y., Mansfield, K. J., Parkin, K., Mukerjee, C., & Moore, K. H. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.10.003 · Cited by 16
Tian, Y., Marshall, M. A., French, B. A., Linden, J. M., & Yang, Z. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0473-x · Cited by 16
Reg-2 expression in dorsal root ganglion neurons after adjuvant-induced monoarthritis
Averill, S., Inglis, J. J., King, V. R., Thompson, S., Cafferty, W. B. J., Shortland, P. J., Hunt, S. P., Kidd, B. L., & Priestley, J. V. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.049 · Cited by 16
Fu, S., & Davies, K. P. (2015) · International Journal of Impotence Research · doi:10.1038/ijir.2015.5 · Cited by 16
Fragakis, N., Antoniadis, A. P., Saviano, M., Vassilikos, V. P., & Pappone, C. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.01.089 · Cited by 16
Purinergic signalling in neuroregeneration
Burnstock, G. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.165300 · Cited by 16
Self-citationRole of A3 adenosine receptor in diabetic neuropathy
Yan, H., Zhang, E., Feng, C., & Zhao, X. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23774 · Cited by 16
Functional and therapeutic importance of purinergic signaling in polycystic kidney disease
Ilatovskaya, D. V., Palygin, O., & Staruschenko, A. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00406.2016 · Cited by 16
Reigada, D., Navarro-Ruíz, R., Caballero-López, M. J., del Águila, Á., Muñoz‐Galdeano, T., Maza, R. M., & Nieto‐Díaz, M. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9541-4 · Cited by 16
Expression of adenosine receptors in monocytes from patients with bronchial asthma
Yuryeva, K., Saltykova, I. V., Ogorodova, L. M., Кириллова, Н. А., Kulikov, E. S., Korotkaya, E., Iakovleva, Y., Feoktistov, I., Сазонов, А. Э., & Ryzhov, S. V. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.07.141 · Cited by 15
Cieślak, M., & Roszek, K. (2014) · Acta Biochimica Polonica · doi:10.18388/abp.2014_1827 · Cited by 15
A mutation causing increased KATP channel activity leads to reduced anxiety in mice
Lahmann, C., Clark, R. H., Iberl, M., & Ashcroft, F. M. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.02.031 · Cited by 15
Ran, H., Duan, W., Gong, Z., Xu, S., Zhu, H., Hou, X., Jiang, L., He, Q., & Zheng, J. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000174 · Cited by 15
UV-B induced alteration in purinergic receptors and signaling on HaCaT keratinocytes
Ruzsnavszky, O., Telek, A., Gönczi, M., Balogh, A., Remenyik, É., & Csernoch, L. J. (2011) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2011.07.009 · Cited by 15
Veselá, R., Aronsson, P., Andersson, M., Wsól, V., & Tobin, G. (2012) · PubMed · Cited by 15
The Use of the Isolated Mouse Whole Bladder for Investigating Bladder Overactivity
Fabiyi, A. C., & Brading, A. F. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.108902 · Cited by 15
Exogenously administered adenosine attenuates renal damage in streptozotocin-induced diabetic rats
Taşkıran, E., Erbaş, O., Yiğittürk, G., Meral, A., Akar, H., & Taşkıran, D. (2016) · Renal Failure · doi:10.1080/0886022x.2016.1207054 · Cited by 15
Role of purinergic signaling in experimental pneumococcal meningitis
Zierhut, M. M., Dyckhoff-Shen, S., Masouris, I., Klein, M., Hammerschmidt, S., Pfister, H., Ayata, C. K., Idzko, M., & Koedel, U. (2017) · Scientific Reports · doi:10.1038/srep44625 · Cited by 15
Chen, N., Qi, L., Wen, J., Zhang, Y., Zhang, W., Wang, W., Blackburn, M. R., Kellems, R. E., & Xia, Y. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02896.x · Cited by 14
Extracellular adenosine controls NKT‐cell‐dependent hepatitis induction
Subramanian, M., Kini, R., Madasu, M. M., Ohta, A., Nowak, M., Mark, E., Sitkovsky, M., & Ohta, A. (2014) · European Journal of Immunology · doi:10.1002/eji.201343866 · Cited by 14
The Search for New Agonists to P2X7R for Clinical Use: Tuberculosis as a Possible Target
Soares‐Bezerra, R. J., Pinho, R. T., Bisaggio, R. D. C., Benévolo-de-Andrade, T. C., & Alves, L. A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430364 · Cited by 14
Mahi, N., Kumar, A., Jaggi, A. S., Singh, N., & Dhawan, R. K. (2015) · Journal of Surgical Research · doi:10.1016/j.jss.2015.02.050 · Cited by 14
Ectonucleotidase expression profile and activity in human cervical cancer cell lines
Beckenkamp, A., Santana, D. B., Bruno, A. N., et al. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2013-0051 · Cited by 14
Novel molecular targets for prevention of obesity and osteoporosis
Rayalam, S., Yang, J., Della‐Fera, M. A., & Baile, C. A. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.11.009 · Cited by 14
Cocaine Shifts the Estrus Cycle Out of Phase and Caffeine Restores It
Broderick, P. A., & Malave, L. B. (2014) · Journal of Caffeine Research · doi:10.1089/jcr.2014.0015 · Cited by 14
Adenosine influences myeloid cells to inhibit aeroallergen sensitization
Pei, H., & Linden, J. M. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00330.2015 · Cited by 14
Danger signals, inflammasomes, and the intricate intracellular lives of chlamydiae
Pettengill, M. A., Sater, A. A. A., Coutinho‐Silva, R., & Ojcius, D. M. (2016) · Biomedical Journal · doi:10.1016/j.bj.2016.07.001 · Cited by 14
Deregulation of Adenosine Receptors in Psoriatic Epidermis: An Option for Therapeutic Treatment
Merighi, S., Borea, P. A., Varani, K., & Gessi, S. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.08.001 · Cited by 14
Evidence for purine nucleoside phosphorylase (PNP) release from rat C6 glioma cells
Giuliani, P., Zuccarini, M., Buccella, S., Peña‐Altamira, E., Polazzi, E., Virgili, M., Monti, B., Poli, A., Rathbone, M. P., Iorio, P. D., et al. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14004 · Cited by 14
Yu, Y., & Zhang, C. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.055 · Cited by 13
Laketa, D., Savić, J., Bjelobaba, I. M., Lavrnja, I. C., Vasić, V., Stojiljković, M., & Nedeljković, N. (2015) · Journal of Medical Biochemistry · doi:10.2478/jomb-2014-0025 · Cited by 13
Huang, J., Zhang, M., Zhang, P., He, L., Ouyang, K., & Yang, H. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9512-9 · Cited by 13
Molz, S., Olescowicz, G., Kraus, J. R., Ludka, F. K., & Tasca, C. I. (2014) · Purinergic Signalling · doi:10.1007/s11302-014-9438-z · Cited by 12
Adenosine: an endogenous mediator in the pathogenesis of psoriasis
Festugato, M. (2015) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20153689 · Cited by 12
Аденозиновый рецептор A2Aкак лекарственная мишень для терапии сепсиса
Сивак, К. В., Vasin, A. V., Egorov, V. V., Цветков, В. Б., Kuzmich, N. N., Savina, V. A., Киселев, О. И., Sivak, K. V., Vasin, А. V., Egorov, V. V., et al. (2016) · Molecular Biology · doi:10.7868/s0026898416020233 · Cited by 12
Long-Term P2Y12-Receptor Antagonists in Post-Myocardial Infarction Patients
Alexopoulos, D. K., Xanthopoulou, I., Μούλιας, Α., & Lekakis, J. P. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.088 · Cited by 12
P2Y purinergic receptor-regulated insulin secretion is mediated by a cAMP/Epac/Kv channel pathway.
Zhang, Y., Guo, Q., Li, X.-D., Gao, J.-Y., Liu, Y.-F., Yang, J., & Li, Q.-S. (2015) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2015.03.121 · Cited by 11
Mendieta-Condado, E., Pichardo-Olvera, M., Sánchez-Sevilla, L., de Sánchez, V. C., & Hernández-Muñoz, R. E. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.156620 · Cited by 11
Dziubina, A., Szmyd, K., Zygmunt, M., Sapa, J., Dudek, M., Filipek, B., Drabczyńska, A., Załuski, M., Pytka, K., & Kieć‐Kononowicz, K. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.07.008 · Cited by 11
Protein Profiling of Bladder Urothelial Cell Carcinoma
Hu, J., Ye, F., Cui, M., Lee, P., Wei, C., Hao, Y., Wang, X., Wang, Y., Lu, Z., Galsky, M. D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161922 · Cited by 11
Zanin, R. F., da Silva, G. L., Erig, T., Sperotto, N. D. D. M., Leite, C. E., Coutinho‐Silva, R., Battastini, A. M. O., & Morrone, F. B. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2381-7 · Cited by 10
Yang, C., Xu, H., Cai, L., Du, X., Jiang, Y., Zhang, Y., Zhou, H., & Chen, Z. K. (2015) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezv413 · Cited by 10
Adenosine Triphosphate Regresses Endometrial Explants in a Rat Model of Endometriosis
Zhang, C., Gao, L., Yi, Y., Han, H., Cheng, H., Ye, X., Ma, R., Sun, K., Cui, H., & Chang, X. (2016) · Reproductive Sciences · doi:10.1177/1933719115625847 · Cited by 10
Rodrigues, L., Miranda, I. M., de Andrade, G. M., Mota, M., Cortes, L., Rodrigues, A. G., Cunha, R. A., & Gonçalves, T. (2016) · Oncotarget · doi:10.18632/oncotarget.11760 · Cited by 10
Go, G., Sung, J., Jee, S.-C., Kim, M., Jang, W.-H., Kang, K., Kim, D.-Y., Lee, S., & Shin, H.-S. (2017) · Food Science and Biotechnology · doi:10.1007/s10068-017-0026-1 · Cited by 10
Akimoto, M., Yunoue, S., Otsubo, H., et al. (2012) · Modern Rheumatology · doi:10.1007/s10165-012-0621-1 · Cited by 9
Suriyaphol, G., Sarikaputi, M., & Suriyaphol, P. (2008) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2008.07.002 · Cited by 9
Role of the Purinergic Receptor P2XR4 After Blunt Chest Trauma in Cigarette Smoke-Exposed Mice
Hafner, S., Wagner, K., Weber, S., Gröger, M., Wepler, M., McCook, O., Scheuerle, A., Stahl, B., Huber-Lang, M. S., Jung, B., et al. (2016) · Shock · doi:10.1097/shk.0000000000000726 · Cited by 9
Update on bipolar disorder biomarker candidates: what about uric acid/adenosine hypothesis?
Bartoli, F., Carrà, G., & Clerici, M. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1270757 · Cited by 9
Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease
Kapila, N., Higa, J. T., Longhi, M. S., & Robson, S. C. (2013) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2013.00015 · Cited by 8
Purinergic signalling during sterile liver injury
de Oliveira, A. G., Marques, P. E., Amaral, S. S., Quintão, J. L. D., Cogliati, B., Dagli, M. L., Rogiers, V., Vanhaecke, T., Vinken, M., & Menezes, G. B. (2013) · Liver International · doi:10.1111/liv.12109 · Cited by 7
Lee, C. Y. (2014) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.12247 · Cited by 7
Blockade and reversal of spinal morphine tolerance by P2X3 receptor antagonist
Ma, X., Xu, T., Xu, H., & Jiang, W. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000105 · Cited by 7
Antipurinergic Therapy with Suramin as a Treatment for Autism Spectrum Disorder
Hamidpour, R., & Hamidpour, S. (2016) · Journal of Biomedical Sciencies · doi:10.4172/2254-609x.100028 · Cited by 7
P2X7 in Bipolar and Depressive Disorders
Barron, M. L., Werry, E. L., McGregor, I. S., & Kassiou, M. (2013) · Springer eBooks · doi:10.1007/978-3-642-40282-1_31 · Cited by 6
The prion protein selectively binds to and modulates the content of purinergic receptor P2X4R
Carneiro, M. V., Americo, T. A., Guimarães, M. Z. P., & Linden, R. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.122 · Cited by 6
Protective Effects of Adenosine Receptor Agonist in a Cirrhotic Liver Resection Model
Iskandarov, E., Srinivasan, P. K., Xin, W., Bleilevens, C., Afify, M., Hamza, A. R., Wei, L., Hata, K., Ağayev, B., & Tolba, R. H. (2016) · Hepatitis Monthly · doi:10.5812/hepatmon.36821 · Cited by 6
de Diego-García, L., Ramirez-Escudero, M., Sebastián‐Serrano, Á., Díaz‐Hernandéz, J. I., Pintor, J. J., Lucas, J. J., & Díaz-Hernández, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.10.012 · Cited by 6
European meeting “P2 receptors: new targets for the treatment of osteoporosis”
Jørgensen, N. R., Boeynaems, J., & Virgilio, F. D. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9223-1 · Cited by 5
Ren, M., Liu, Y., Zhao, H., Dong, S., Jiang, Z., Li, K., & Tian, J. (2016) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12205 · Cited by 5
Targeting Purinergic Receptors in Islet Transplantation
Aikin, R. A. (2013) · Diabetes · doi:10.2337/db13-0211 · Cited by 4
One drug, two outcomes after atrial fibrillation ablation: the situational irony of adenosine
Bunch, T. J. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv473 · Cited by 4
Colligative Property of ATP: Implications for Enteric Purinergic Neuromuscular Neurotransmission
Chaudhury, A., Dendi, V. S., & Mirza, W. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00500 · Cited by 4
The role of adenosine receptor agonists in ocular disorders
Lee, D., Myers, J. S., & Katz, L. J. (2016) · Drugs of the Future · doi:10.1358/dof.2016.041.09.2533858 · Cited by 4
Ma, B., Jiang, Q., Li, W., & Li, Z. (2016) · The FASEB Journal · doi:10.1096/fasebj.30.1_supplement.1023.4 · Cited by 4
Yu, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.050 · Cited by 3
Purinergic signaling-induced neuroinflammation and status epilepticus
Engel, T. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1164036 · Cited by 3
Adenosine in the Neurobiology of Schizophrenia: Potential Adenosine Receptor-Based Pharmacotherapy
Ciruela, F., Fernández‐Dueñas, V., Contreras, F., Arnau, J. M., Menchón, J. M., Vallano, A., & Valle-León, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-17103-6_26 · Cited by 3
Purinergic Receptors and Pain - An Update
(2016) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781681082493116090003 · Cited by 3
Physiological and Pathological Inflammation at the Mucosal Frontline
Kurashima, Y., & Kiyono, H. (2016) · Springer eBooks · doi:10.1007/978-4-431-56068-5_43 · Cited by 3
Osteoclast-Mediated Pain in Osteoporosis
Iba, K., & Yamashita, T. (2015) · Springer eBooks · doi:10.1007/978-4-431-55778-4_2 · Cited by 1
Feng, J. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3853 · Cited by 1
Cited by
The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
Savio, L. E. B., de Andrade Mello, P., da Silva, C. G., & Coutinho-Silva, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00052 · Cited by 437
Danger signals in stroke and their role on microglia activation after ischemia
Gülke, E., Gelderblom, M., & Magnus, T. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418774254 · Cited by 321
Mechanisms of ATP Release by Inflammatory Cells
Dosch, M., Gerber, J., Jebbawi, F., & Beldi, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041222 · Cited by 283
Metadata
- Authors
- Burnstock, G.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2017-09-25
- Volume
- 8
- Pages
- 661-661
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2759752974
- Cited by
- 398
- References
- 724
- FWCI
- 28.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.